CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
The following is a description of transactions since January 1, 2022, to which we were a party in which the amount involved exceeded or will exceed $120,000, and in which any of our executive officers, directors or holders of more than 5% of any class of our voting securities, or an affiliate or immediate family member thereof, had or will have a direct or indirect material interest.
Sales of Products and Services
The Goldman Sachs Group, Inc. and some of its affiliates, each an affiliate of our Sponsor, are clients of ours and we had sales of certain products and services to Goldman Sachs and affiliates of approximately $5.8 million in the year ended December 31, 2022, and approximately $1.1 million in the three months ended March 31, 2023. Outstanding accounts receivable from Goldman Sachs and affiliates as of December 31, 2022 and March 31, 2023 were $0.2 million and $0.6 million, respectively. In addition, on February 28, 2023, we entered into an amortizing $300.0 million notional value interest rate swap, $75.0 million of which was entered into with J. Aron & Company LLC, a wholly-owned subsidiary of Goldman Sachs. Outstanding accounts receivable from J. Aron & Company LLC as of March 31, 2023 were less than $0.1 million.
Field Control Analytics, an affiliate of the Greenblatt Trusts (see “Security Ownership of Certain Beneficial Owners and Management Table”), is a client of ours and we had sales of certain products and services to Field Control Analytics of approximately $0.3 million in the year ended December 31, 2022 and $0.1 million in the three months ended March 31, 2023. Outstanding accounts receivable from Field Control Analytics were less than $0.1 million as of December 31, 2022 and $0.1 million as of March 31, 2023.
Our Board consists of eight members, which includes Mr. Jones who is affiliated with our Sponsor (See “Corporate Governance—Controlled Company Exception and Director Independence”). Messrs. Crampton and Chen were also members of our Board and were not independent due to their affiliation with our Sponsor. Mr. Crampton resigned from the Board effective December 31, 2022 and Mr. Chen resigned from the Board effective March 8, 2023. Mr. Rubado previously was not independent due to his affiliation with our Sponsor. However, as of March 10, 2023, Mr. Rubado was no longer an employee of CDPQ and as a result, our Board determined that Mr. Rubado is an independent director. Mr. Rubado has not been nominated for re-election at the Annual Meeting and will retire from the Board at the expiration of his term at the Annual Meeting. The Board has nominated Mr. Villon to stand for election as a Class II director as of the Annual Meeting. The Board has determined that Mr. Villon is not independent due to his affiliation with our Sponsor.
Related Party Transactions Entered Into in Connection with the IPO
Stockholders’ Agreement
In connection with our IPO, on September 22, 2021, we entered into an amended and restated stockholders’ agreement with affiliates of Goldman Sachs and certain other stockholders setting forth certain demand and piggyback registration rights. Following our IPO, certain stockholders waived their rights under our amended and restated stockholders’ agreement.
Pursuant to the amended and restated stockholders’ agreement, our Sponsor, who owns approximately 61.3% of our common stock as of April 4, 2023, caused us to file the Registration Statement on Form S-3 and related prospectus dated January 24, 2023, whereby we registered 59,953,230 shares of common stock held by our Sponsor as well as 1,075,809 shares of common stock held by other selling stockholders, including certain directors and executive officers of the Company, as of such date for resale from time to time in one or more offerings or resales. Pursuant to the amended and restated stockholders’ agreement, our Sponsor has the right, subject to certain conditions, to require us to facilitate offerings of its shares of our common stock, which would result in such shares becoming freely tradable without restriction under the Securities Act, except to the extent purchased by our affiliates (as defined in Rule 144 under the Securities Act).